SCHEMBL6891384

SCHEMBL6891384

COP(=O)(Cc1ccc(NC(=O)c2cc(=O)c3ccccc3o2)cc1)OC

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.67
MAPT P10636 7/20 0.67
MEN1 O00255 5/20 0.67
POLB P06746 3/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
NPC1 O15118 1/20 0.67
HTT P42858 1/20 0.67
RAB9A P51151 1/20 0.67
MAOA P21397 2/20 0.65
MAOB P27338 2/20 0.65
ALDH1A1 P00352 2/20 0.61
DUSP3 P51452 1/20 0.61
PTPN11 Q06124 1/20 0.61
LMNA P02545 1/20 0.61
RXFP1 Q9HBX9 1/20 0.57
RECQL P46063 1/20 0.56
TP53 P04637 1/20 0.55
ABCB1 P08183 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8667238 0.89 KMT2A (0.65) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8641561 0.89 KMT2A (0.68) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL7591296 0.89 KMT2A (0.65) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8642632 0.86 MAOA (0.71) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8647533 0.84 KMT2A (0.70) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL12501713 0.82 KMT2A (0.78) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8639943 0.82 KMT2A (0.49) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8643667 0.81 KMT2A (0.62) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8641342 0.81 HCRTR1 (0.53) KMT2AMAPTMEN1POLBSMN1; SMN2
SCHEMBL8642829 0.81 KMT2A (0.53) KMT2AMAPTMEN1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5580863-A TREATMENT OF OSTEOPOROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-03 US claimed
EP-1023044-B1 APATITE-COATED SOLID COMPOSITION TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-02-04 EP disclosed
US-6344209-B1 BIODEGRADABLE POLYLACTIC ACID, POLYGLYCOLIC ACID AND COPOLYMERS OF THE TWO FOR BONE DISEASES THERAPY; ANTIBIOTICS, ANTI-INFLAMMATORY AND ANTI-TUMOR AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-02-05 US disclosed
EP-1023044-A2 APATITE-COATED SOLID COMPOSITION Takeda Chemical Industries, Ltd. (JP) 2000-08-02 EP disclosed
US-5910492-A PREVENTION AND TREATMENT OF BONE DISEASES, REPAIR OF BONE TISSUE, REGENERATION OF PERIODONTAL TISSUE; SHORTENED HEALING TIME TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-06-08 US disclosed
WO-1998047485-A2 APATITE-COATED SOLID COMPOSITION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-29 WO disclosed
EP-0625522-B1 Benzopyran derivatives and their use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-08-19 EP disclosed
US-5741784-A ADMINISTERING TO TREAT METABOLIC BONE DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-21 US disclosed
EP-0831808-A1 OSTEOGENETIC PROMOTING PHARMACEUTICAL COMPOSITION Takeda Chemical Industries, Ltd. (JP) 1998-04-01 EP disclosed
WO-1996039134-A1 OSTEOGENETIC PROMOTING PHARMACEUTICAL COMPOSITION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-12 WO disclosed
US-5580863-A TREATMENT OF OSTEOPOROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-03 US disclosed
EP-0625522-A1 Benzopyran derivatives and their use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-23 EP disclosed